Valeritas touted real-world data from 3 separate studies of its V-Go insulin delivery system showcasing the device’s utility and effectiveness.
V-Go is a disposable, wearable insulin delivery device designed to deliver a preset dosage continually over 24 hours and on-demand doses during meals.
Direct Flow Medical today said data from a clinical trial of its replacement heart valve showed an 80% survival rate after 2 years.
OrbusNeich Medical said today that it enrolled the 1st U.S. patient in a pivotal trial of its dual-therapy Combo stent.
Biotronik‘s Iforia ProMRI implantable cardioverter defibrillator is safe for use in 1.5T MRI scanners, researchers announced today at the Heart Rhythm Society’s annual meeting in Boston.